跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FIBRYGA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FIBRYGA
Authorized
STANDARD
FIBRYGA
octapharma pharmazeutika produktionsges m b h
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4335cc051f5b3c6e
Company
octapharma pharmazeutika produktionsges m b h
Type
Standard
Approval Details
Approval Id
4335cc051f5b3c6e
Drug Approval Canada Name
FIBRYGA
Product Name
FIBRYGA
Status
Marketed
Status Date
2018-08-08
Original Market Date
2018-08-08
Din
02464616
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BB01 FIBRINOGEN, HUMAN
Atc Name
b 02 bb 01
Aig Number
0153289002
Company Name
octapharma pharmazeutika produktionsges m b h
Company Address
Oberlaaer Strasse 235, Vienna, Vienne, Austria, 1100
Active Ingredients
FIBRINOGEN (HUMAN)
1 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4335cc051f5b3c6e
Type
Standard
Back to Health Canada Approvals